BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct03943472 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Refractory Multiple Myeloma

Download Full-text

Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma

Journal of International Medical Research ◽

10.1177/0300060519893496 ◽

2020 ◽

Vol 48 (1) ◽

pp. 030006051989349

Author(s):

Fang Tang ◽

Yin Lu ◽

Yongqin Ge ◽

Jingjing Shang ◽

Xiaming Zhu

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

B Cell ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Cell Maturation ◽

Refractory Multiple Myeloma ◽

B Cell Maturation ◽

B Cell Maturation Antigen

Download Full-text

B cell maturation antigen‐specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta‐analysis

European Journal Of Haematology ◽

10.1111/ejh.13380 ◽

2020 ◽

Vol 104 (4) ◽

pp. 318-327 ◽

Author(s):

Nico Gagelmann ◽

Francis Ayuk ◽

Djordje Atanackovic ◽

Nicolaus Kröger

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

B Cell ◽

Chimeric Antigen Receptor ◽

Meta Analysis ◽

Antigen Receptor ◽

Cell Maturation ◽

Refractory Multiple Myeloma ◽

B Cell Maturation ◽

B Cell Maturation Antigen

Download Full-text

Effective Treatment of Relapsed/Refractory Multiple Myeloma by Bi-Epitope BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

SSRN Electronic Journal ◽

10.2139/ssrn.3228241 ◽

2018 ◽

Author(s):

Jie Xu ◽

Li-Juan Chen ◽

Shuang-Shuang Yang ◽

Yan Sun ◽

Wen Wu ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Effective Treatment ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Refractory Multiple Myeloma

Download Full-text

Faculty Opinions recommendation of Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726133199.793514498 ◽

2016 ◽

Author(s):

Daniele Prati ◽

Alessandra Berzuini

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Clinical Evaluation ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Engineered T Cells

Download Full-text

Novel BCMA-OR-CD38 tandem-dual chimeric antigen receptor T cells robustly control multiple myeloma

OncoImmunology ◽

10.1080/2162402x.2021.1959102 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1959102

Author(s):

Yaru Feng ◽

Xiuying Liu ◽

Xiaorui Li ◽

Yating Zhou ◽

Zhiru Song ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Antigen Receptor

Download Full-text

Preclinical assessment of LCAR-B38M, a novel BCMA-targeting chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory multiple myeloma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.09.267 ◽

2019 ◽

Vol 19 (10) ◽

pp. e160 ◽

Author(s):

Xiaohu (Frank) Fan ◽

Qiuchuan Zhuang ◽

Lei Yang ◽

Jiaying Hao ◽

Dan Zhao ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cell ◽

Cell Therapy ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

T Cell Therapy ◽

Refractory Multiple Myeloma ◽

Car T Cell Therapy ◽

Download Full-text

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-3-s2-p117 ◽

2015 ◽

Vol 3 (S2) ◽

Author(s):

Alden Ladd ◽

Graham Lilley ◽

Mingli Li ◽

Dan Cossette ◽

Gregory W Hopkins ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Manufacturing Process ◽

Ex Vivo ◽

Antigen Receptor ◽

Ex Vivo Expansion ◽

Genetically Engineered

Download Full-text

Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment

Bone Marrow Transplantation ◽

10.1038/s41409-020-0930-5 ◽

2020 ◽

Vol 55 (11) ◽

pp. 2215-2218

Author(s):

Hujun Li ◽

Lingling Yin ◽

Ying Wang ◽

Xiangmin Wang ◽

Ming Shi ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cell ◽

Renal Impairment ◽

Cell Therapy ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

T Cell Therapy ◽

Safety And Efficacy ◽

Refractory Multiple Myeloma

Download Full-text

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

Biomarker Research ◽

10.1186/s40364-020-00192-6 ◽

2020 ◽

Vol 8 (1) ◽

Author(s):

Liqing Kang ◽

Jian Zhang ◽

Minghao Li ◽

Nan Xu ◽

Wei Qi ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Antigen Receptor

Download Full-text

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-0344 ◽

2017 ◽

Vol 24 (1) ◽

pp. 106-119 ◽

Author(s):

Xiuli Wang ◽

Miriam Walter ◽

Ryan Urak ◽

Lihong Weng ◽

Christian Huynh ◽

...

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Antigen Receptor

Download Full-text